CLINICAL_TRIALS
withdrawal
· 2017-03-09
Clinical Trial Update: PRO 140 for Human Immunodeficiency Virus Infection [Phase 2]
Summary
A Phase 2 clinical trial of PRO 140 for HIV infection has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Drexel University | Conditions: HIV | Phase 2 | Status: WITHDRAWN